Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.

about

What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?

P2860

Q42359420-2B9F4D66-B4DB-41DB-81D0-BA4EF3AE4590

P2860

Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.

Item

http://www.wikidata.org/entity/Q39019096

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@en

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@nl

type

Item

label

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@en

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@nl

prefLabel

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@en

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@nl

P1476

Pharmacokinetic/pharmacodynami ...... iae and Pasteurella multocida.

@en

P2093

L Dorey

http://www.w3.org/2001/XMLSchema#string

L Pelligand

http://www.w3.org/2001/XMLSchema#string

P Lees

http://www.w3.org/2001/XMLSchema#string

Z Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.

Plasma clearance.

Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.

The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration.

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.

Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.

Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs.

Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.

P304

505-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVP.12385

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28090673

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer

P932

5600110

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.

about

P2860

P2860

Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932